Tardive dyskinesia is a hyperkinetic movement disorder that causes faces to move involuntarily and abnormally. It is considered to be a drug-induced movement disorder. Movements often occur in the ...

Teva Pharmaceuticals has announced new real-world data showing that AUSTEDO (deutetrabenazine) tablets and AUSTEDO XR ...

—With the support of a leading scientific organization, a group of U.S.-based researchers designed 3 rounds of questionnaires to decide which term neurologists and psychiatrists should adopt going ...

Tardive dyskinesia is a common side effect caused by antipsychotic use. It is a neurological disorder characterized by involuntary, repetitive movements, often involving the face, mouth, tongue, and ...

Involuntary movements caused by tardive dyskinesia (TD), a movement disorder induced by dopamine-receptor antagonists like ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription ...

Study reveals over half of long-term care residents with tardive dyskinesia do not receive standard treatment, highlighting care gaps. Less than half of patients diagnosed with tardive dyskinesia in ...

Many people like to snack on peanut butter with apple slices for the vitamin E, but you have to be careful of other ...

So one of the trials that I'm interested in watching is an extension trial of the IMPACT-TD registry that's currently going on and being done by Teva Pharmaceuticals, who are the manufacturers of ...

A Pennsylvania congressman is expected to be the president’s pick to be the next drug czar. While there hasn’t been an official announcement, the head of the Pennsylvania Republican Party said ...

Teva Pharmaceuticals has a new game plan for raising awareness of tardive dyskinesia (TD). | Teva Pharmaceuticals has a new ...